Form 8-K - Current report:
SEC Accession No. 0001558370-20-011983
Filing Date
2020-10-29
Accepted
2020-10-29 08:00:32
Documents
13
Period of Report
2020-10-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpmc-20201029x8k.htm   iXBRL 8-K 41058
2 EX-99.1 bpmc-20201029xex99d1.htm EX-99.1 120371
  Complete submission text file 0001558370-20-011983.txt   293348

Data Files

Seq Description Document Type Size
3 EX-101.SCH bpmc-20201029.xsd EX-101.SCH 3243
4 EX-101.LAB bpmc-20201029_lab.xml EX-101.LAB 15503
5 EX-101.PRE bpmc-20201029_pre.xml EX-101.PRE 10532
6 EXTRACTED XBRL INSTANCE DOCUMENT bpmc-20201029x8k_htm.xml XML 4725
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37359 | Film No.: 201270588
SIC: 2834 Pharmaceutical Preparations